company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 16:10:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 16:10:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 16:10:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1912000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 16:10:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1194000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 16:10:34+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 16:10:34+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 16:10:34+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 16:10:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3106000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 16:10:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3106000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 16:10:34+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5621000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 16:10:34+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 16:10:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5621000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 16:10:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8727000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 16:10:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8727000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 16:10:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8727000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 16:10:34+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 16:10:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8727000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 16:10:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,62300000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 16:10:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.14
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 16:10:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,62300000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 16:10:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.14
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 16:10:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,63853000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 16:10:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.14
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 14:49:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 14:49:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 14:49:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 14:49:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 14:49:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1412000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 14:49:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1606000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 14:49:33+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,2000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 14:49:33+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 14:49:33+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 14:49:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3020000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 14:49:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3010000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 14:49:33+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2371000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 14:49:33+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 14:49:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2371000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 14:49:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5381000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 14:49:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5381000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 14:49:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5381000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 14:49:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5381000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 14:49:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,70413000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 14:49:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 14:49:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,70413000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 14:49:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 14:49:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,67300000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 14:49:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2316000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4440000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6756000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6756000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1491000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-161000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1652000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8408000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8408000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8408000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8408000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,77087000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,76400000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,76400000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 16:10:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 16:10:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 16:10:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5555000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 16:10:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3469000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 16:10:34+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,4000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 16:10:34+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 16:10:34+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 16:10:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9028000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 16:10:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9028000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 16:10:34+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1690000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 16:10:34+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1610000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 16:10:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3300000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 16:10:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12328000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 16:10:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12328000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 16:10:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12328000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 16:10:34+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 16:10:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12328000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 16:10:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,82200000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 16:10:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 16:10:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,82200000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 16:10:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 16:10:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,83890000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 16:10:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 13:08:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 13:08:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 13:08:05+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 13:08:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 13:08:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2804000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 13:08:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3565000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 13:08:05+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,2000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 13:08:05+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 13:08:05+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 13:08:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6371000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 13:08:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6361000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 13:08:05+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2370000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 13:08:05+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,9213000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 13:08:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,6843000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 13:08:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,482000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 13:08:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,482000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 13:08:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,482000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 13:08:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,482000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 13:08:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5945000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 13:08:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.08
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 13:08:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,7696000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 13:08:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.06
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 13:08:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6000000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 13:08:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.08
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2660000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1978000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,4000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4642000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4642000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10041000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2107000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7934000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12576000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12576000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12576000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12576000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5900000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-5.4
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,5900000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-5.38
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,5887000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-5.4
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2183000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3580000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,2000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5765000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5765000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5225000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,839000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4386000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10151000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10151000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10151000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10151000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,153584000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,145000000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,145000000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.07
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,2012-04-01,2012-06-30,2013-08-14 17:52:46+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,330000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,2012-04-01,2012-06-30,2013-08-14 17:52:46+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,330000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,2012-04-01,2012-06-30,2013-08-14 17:52:46+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,2012-04-01,2012-06-30,2013-08-14 17:52:46+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,330000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,2012-04-01,2012-06-30,2013-08-14 17:52:46+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2025000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,2012-04-01,2012-06-30,2013-08-14 17:52:46+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7040000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,2012-04-01,2012-06-30,2013-08-14 17:52:46+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,2000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,2012-04-01,2012-06-30,2013-08-14 17:52:46+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,2012-04-01,2012-06-30,2013-08-14 17:52:46+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,2012-04-01,2012-06-30,2013-08-14 17:52:46+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9067000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,2012-04-01,2012-06-30,2013-08-14 17:52:46+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8737000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,2012-04-01,2012-06-30,2013-08-14 17:52:46+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1613000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,2012-04-01,2012-06-30,2013-08-14 17:52:46+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,200000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,2012-04-01,2012-06-30,2013-08-14 17:52:46+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1413000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,2012-04-01,2012-06-30,2013-08-14 17:52:46+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10150000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,2012-04-01,2012-06-30,2013-08-14 17:52:46+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10150000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,2012-04-01,2012-06-30,2013-08-14 17:52:46+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10150000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,2012-04-01,2012-06-30,2013-08-14 17:52:46+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10150000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,2012-04-01,2012-06-30,2013-08-14 17:52:46+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,169200000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,2012-04-01,2012-06-30,2013-08-14 17:52:46+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,2012-04-01,2012-06-30,2013-08-14 17:52:46+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,169200000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,2012-04-01,2012-06-30,2013-08-14 17:52:46+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,2012-04-01,2012-06-30,2013-08-14 17:52:46+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,162357000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,2012-04-01,2012-06-30,2013-08-14 17:52:46+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,2012-07-01,2012-09-30,2013-11-15 13:11:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,120000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,2012-07-01,2012-09-30,2013-11-15 13:11:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,120000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,2012-07-01,2012-09-30,2013-11-15 13:11:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,2012-07-01,2012-09-30,2013-11-15 13:11:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,120000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,2012-07-01,2012-09-30,2013-11-15 13:11:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3913000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,2012-07-01,2012-09-30,2013-11-15 13:11:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9944000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,2012-07-01,2012-09-30,2013-11-15 13:11:21+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,5000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,2012-07-01,2012-09-30,2013-11-15 13:11:21+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,2012-07-01,2012-09-30,2013-11-15 13:11:21+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,2012-07-01,2012-09-30,2013-11-15 13:11:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13862000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,2012-07-01,2012-09-30,2013-11-15 13:11:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13742000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,2012-07-01,2012-09-30,2013-11-15 13:11:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2788000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,2012-07-01,2012-09-30,2013-11-15 13:11:21+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,2012-07-01,2012-09-30,2013-11-15 13:11:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,35000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,2012-07-01,2012-09-30,2013-11-15 13:11:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2753000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,2012-07-01,2012-09-30,2013-11-15 13:11:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16495000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,2012-07-01,2012-09-30,2013-11-15 13:11:21+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,2012-07-01,2012-09-30,2013-11-15 13:11:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16495000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,2012-07-01,2012-09-30,2013-11-15 13:11:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16495000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,2012-07-01,2012-09-30,2013-11-15 13:11:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16495000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,2012-07-01,2012-09-30,2013-11-15 13:11:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,11000000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,2012-07-01,2012-09-30,2013-11-15 13:11:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.5
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,2012-07-01,2012-09-30,2013-11-15 13:11:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,11000000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,2012-07-01,2012-09-30,2013-11-15 13:11:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.5
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,2012-07-01,2012-09-30,2013-11-15 13:11:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,11029000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,2012-07-01,2012-09-30,2013-11-15 13:11:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.5
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,322000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,322000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,322000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7554000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8344000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,5000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15903000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15581000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,12919000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-2590000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,566000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-14943000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-30524000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30524000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30524000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-30524000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,11800000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-4.09
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,11800000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-4.09
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,11759000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-4.09
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,137000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,137000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,137000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2470000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11608000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,3000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14081000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13944000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,450000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-450000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14394000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14394000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14394000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14394000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,26700000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.54
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,26700000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.54
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,26710000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.54
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,2013-04-01,2013-06-30,2014-08-15 06:02:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,272000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,2013-04-01,2013-06-30,2014-08-15 06:02:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,272000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,2013-04-01,2013-06-30,2014-08-15 06:02:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,272000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,2013-04-01,2013-06-30,2014-08-15 06:02:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3290000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,2013-04-01,2013-06-30,2014-08-15 06:02:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8383000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,2013-04-01,2013-06-30,2014-08-15 06:02:07+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,3000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,2013-04-01,2013-06-30,2014-08-15 06:02:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11676000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,2013-04-01,2013-06-30,2014-08-15 06:02:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11404000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,2013-04-01,2013-06-30,2014-08-15 06:02:07+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,190000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,2013-04-01,2013-06-30,2014-08-15 06:02:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,2013-04-01,2013-06-30,2014-08-15 06:02:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-190000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,2013-04-01,2013-06-30,2014-08-15 06:02:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11594000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,2013-04-01,2013-06-30,2014-08-15 06:02:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11594000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,2013-04-01,2013-06-30,2014-08-15 06:02:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11594000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,2013-04-01,2013-06-30,2014-08-15 06:02:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11594000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,2013-04-01,2013-06-30,2014-08-15 06:02:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29000000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,2013-04-01,2013-06-30,2014-08-15 06:02:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.4
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,2013-04-01,2013-06-30,2014-08-15 06:02:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29000000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,2013-04-01,2013-06-30,2014-08-15 06:02:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.4
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,2013-04-01,2013-06-30,2014-08-15 06:02:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29105000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,2013-04-01,2013-06-30,2014-08-15 06:02:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.4
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,2013-07-01,2013-09-30,2014-11-19 15:25:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,400000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,2013-07-01,2013-09-30,2014-11-19 15:25:00+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,400000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,2013-07-01,2013-09-30,2014-11-19 15:25:00+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,400000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,2013-07-01,2013-09-30,2014-11-19 15:25:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3059000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,2013-07-01,2013-09-30,2014-11-19 15:25:00+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12794000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,2013-07-01,2013-09-30,2014-11-19 15:25:00+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,3000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,2013-07-01,2013-09-30,2014-11-19 15:25:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15856000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,2013-07-01,2013-09-30,2014-11-19 15:25:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15456000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,2013-07-01,2013-09-30,2014-11-19 15:25:00+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7517000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,2013-07-01,2013-09-30,2014-11-19 15:25:00+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,63000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,2013-07-01,2013-09-30,2014-11-19 15:25:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7454000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,2013-07-01,2013-09-30,2014-11-19 15:25:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-22910000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,2013-07-01,2013-09-30,2014-11-19 15:25:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22910000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,2013-07-01,2013-09-30,2014-11-19 15:25:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22910000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,2013-07-01,2013-09-30,2014-11-19 15:25:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22910000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,2013-07-01,2013-09-30,2014-11-19 15:25:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,35200000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,2013-07-01,2013-09-30,2014-11-19 15:25:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.65
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,2013-07-01,2013-09-30,2014-11-19 15:25:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,35200000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,2013-07-01,2013-09-30,2014-11-19 15:25:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.65
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,2013-07-01,2013-09-30,2014-11-19 15:25:00+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,35275000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,2013-07-01,2013-09-30,2014-11-19 15:25:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.65
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3558000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11121000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,-9000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14670000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14670000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3284000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-31000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1094000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2221000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16891000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16891000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16891000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16891000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32900000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.41
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,32900000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.41
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32865000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.41
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:21:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:21:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3693000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:21:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19986000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:21:10+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,3000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:21:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23682000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:21:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-23682000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:21:10+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5373000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:21:10+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-16986000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:21:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-22359000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:21:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-46041000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:21:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-46041000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:21:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-46041000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:21:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-46041000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:21:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,52300000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:21:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.88
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:21:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,52300000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:21:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.88
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:21:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,52377000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:21:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.88
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:03:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:03:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3878000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:03:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21549000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:03:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25427000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:03:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-25427000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:03:26+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5122000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:03:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4684000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:03:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-438000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:03:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-25865000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:03:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25865000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:03:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25865000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:03:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-25865000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:03:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,57500000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:03:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.45
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:03:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,57500000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:03:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.45
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:03:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,57442000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:03:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.45
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:54:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,582000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:54:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,582000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:54:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,582000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:54:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4483000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:54:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,22707000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:54:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27190000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:54:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-26608000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:54:45+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,8437000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:54:45+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,14002000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:54:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,5565000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:54:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-21043000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:54:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21043000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:54:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21043000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:54:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-21043000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:54:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,60604000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:54:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.35
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:54:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,60604000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:54:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.35
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:54:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,60100000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:54:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.35
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,872000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,872000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,872000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4906000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21395000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,-3000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26298000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-25426000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,969000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-16739000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-17708000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-43134000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,449000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-42685000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-42685000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-42685000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,59200000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.61
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,59200000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.61
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,59248000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.61
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 19:46:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,194000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 19:46:06+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,194000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 19:46:06+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,194000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 19:46:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3400000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 19:46:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19625000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 19:46:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23025000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 19:46:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22831000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 19:46:06+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,793000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 19:46:06+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-22809000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 19:46:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-23602000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 19:46:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-46433000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 19:46:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-46433000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 19:46:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-46433000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 19:46:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-46433000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 19:46:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,69300000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 19:46:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.67
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 19:46:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,69300000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 19:46:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.67
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 19:46:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,69406000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 19:46:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.67
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:10:29+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,391000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:10:29+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,391000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:10:29+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,391000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:10:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11446000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:10:29+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27799000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:10:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,39245000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:10:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-38854000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:10:29+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1636000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:10:29+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:10:29+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-26355000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:10:29+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-27991000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:10:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-66845000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:10:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-66845000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:10:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-66845000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:10:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-66845000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:10:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,76000000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:10:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.88
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:10:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,76000000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:10:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.88
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:10:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,75619000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:10:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.88
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,2015-07-01,2015-09-30,2016-11-10 16:32:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,291000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,2015-07-01,2015-09-30,2016-11-10 16:32:43+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,291000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,2015-07-01,2015-09-30,2016-11-10 16:32:43+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,291000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,2015-07-01,2015-09-30,2016-11-10 16:32:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4366000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,2015-07-01,2015-09-30,2016-11-10 16:32:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9138000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,2015-07-01,2015-09-30,2016-11-10 16:32:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13504000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,2015-07-01,2015-09-30,2016-11-10 16:32:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13213000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,2015-07-01,2015-09-30,2016-11-10 16:32:43+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1046000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,2015-07-01,2015-09-30,2016-11-10 16:32:43+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,2015-07-01,2015-09-30,2016-11-10 16:32:43+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,36874000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,2015-07-01,2015-09-30,2016-11-10 16:32:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,35828000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,2015-07-01,2015-09-30,2016-11-10 16:32:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,22615000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,2015-07-01,2015-09-30,2016-11-10 16:32:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,22615000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,2015-07-01,2015-09-30,2016-11-10 16:32:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,22615000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,2015-07-01,2015-09-30,2016-11-10 16:32:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,22615000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,2015-07-01,2015-09-30,2016-11-10 16:32:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,78062000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,2015-07-01,2015-09-30,2016-11-10 16:32:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.29
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,2015-07-01,2015-09-30,2016-11-10 16:32:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,89821000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,2015-07-01,2015-09-30,2016-11-10 16:32:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.25
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,2015-07-01,2015-09-30,2016-11-10 16:32:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,78000000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,2015-07-01,2015-09-30,2016-11-10 16:32:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.29
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,863000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,863000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,863000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,-886000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,46558000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,6577000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,52249000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-51386000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,678000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,27986000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,27308000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-24078000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24078000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24078000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-24078000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,77500000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.22
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,77500000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.18
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,77713000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.22
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 17:25:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,236000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 17:25:22+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,236000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 17:25:22+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,236000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 17:25:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3335000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 17:25:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13440000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 17:25:22+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,940000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 17:25:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17715000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 17:25:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17479000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 17:25:22+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,718000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 17:25:22+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,12091000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 17:25:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,11373000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 17:25:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6106000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 17:25:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6106000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 17:25:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6106000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 17:25:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6106000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 17:25:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,101800000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 17:25:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 17:25:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,101800000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 17:25:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 17:25:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,97688000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 17:25:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,2016-04-01,2016-06-30,2017-08-21 16:37:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,157000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,2016-04-01,2016-06-30,2017-08-21 16:37:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,157000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,2016-04-01,2016-06-30,2017-08-21 16:37:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,157000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,2016-04-01,2016-06-30,2017-08-21 16:37:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1926000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,2016-04-01,2016-06-30,2017-08-21 16:37:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8713000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,2016-04-01,2016-06-30,2017-08-21 16:37:12+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,4541000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,2016-04-01,2016-06-30,2017-08-21 16:37:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15180000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,2016-04-01,2016-06-30,2017-08-21 16:37:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15023000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,2016-04-01,2016-06-30,2017-08-21 16:37:12+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,729000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,2016-04-01,2016-06-30,2017-08-21 16:37:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1577000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,2016-04-01,2016-06-30,2017-08-21 16:37:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,848000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,2016-04-01,2016-06-30,2017-08-21 16:37:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14175000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,2016-04-01,2016-06-30,2017-08-21 16:37:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14175000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,2016-04-01,2016-06-30,2017-08-21 16:37:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14175000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,2016-04-01,2016-06-30,2017-08-21 16:37:12+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,2640000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,2016-04-01,2016-06-30,2017-08-21 16:37:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16815000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,2016-04-01,2016-06-30,2017-08-21 16:37:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,105100000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,2016-04-01,2016-06-30,2017-08-21 16:37:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.16
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,2016-04-01,2016-06-30,2017-08-21 16:37:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,105100000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,2016-04-01,2016-06-30,2017-08-21 16:37:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.16
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,2016-04-01,2016-06-30,2017-08-21 16:37:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,103831000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,2016-04-01,2016-06-30,2017-08-21 16:37:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.16
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,2016-07-01,2016-09-30,2017-11-20 17:30:39+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,159000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,2016-07-01,2016-09-30,2017-11-20 17:30:39+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,159000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,2016-07-01,2016-09-30,2017-11-20 17:30:39+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,159000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,2016-07-01,2016-09-30,2017-11-20 17:30:39+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2668000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,2016-07-01,2016-09-30,2017-11-20 17:30:39+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21094000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,2016-07-01,2016-09-30,2017-11-20 17:30:39+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1913000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,2016-07-01,2016-09-30,2017-11-20 17:30:39+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25675000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,2016-07-01,2016-09-30,2017-11-20 17:30:39+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-25516000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,2016-07-01,2016-09-30,2017-11-20 17:30:39+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2581000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,2016-07-01,2016-09-30,2017-11-20 17:30:39+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1130000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,2016-07-01,2016-09-30,2017-11-20 17:30:39+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3711000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,2016-07-01,2016-09-30,2017-11-20 17:30:39+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-29227000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,2016-07-01,2016-09-30,2017-11-20 17:30:39+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29227000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,2016-07-01,2016-09-30,2017-11-20 17:30:39+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29227000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,2016-07-01,2016-09-30,2017-11-20 17:30:39+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,3007000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,2016-07-01,2016-09-30,2017-11-20 17:30:39+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-32234000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,2016-07-01,2016-09-30,2017-11-20 17:30:39+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,115100000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,2016-07-01,2016-09-30,2017-11-20 17:30:39+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.28
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,2016-07-01,2016-09-30,2017-11-20 17:30:39+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,115100000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,2016-07-01,2016-09-30,2017-11-20 17:30:39+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.28
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,2016-07-01,2016-09-30,2017-11-20 17:30:39+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114836000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,2016-07-01,2016-09-30,2017-11-20 17:30:39+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,71000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,71000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,71000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2938000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16834000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1547000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21319000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-21248000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2399000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-5680000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1379000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9458000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-30706000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30706000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30706000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-30706000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,111500000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.27
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,111500000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.27
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,111078000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.27
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,68000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,68000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,68000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3005000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5035000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,3932000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11972000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11904000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2729000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2013000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-716000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12620000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12620000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12620000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12620000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,157800000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,157800000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,161498000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 16:48:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,88000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 16:48:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,88000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 16:48:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,88000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 16:48:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3284000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 16:48:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5466000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 16:48:03+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,2003000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 16:48:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10753000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 16:48:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10665000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 16:48:03+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,8315000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 16:48:03+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,8727000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 16:48:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,412000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 16:48:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10253000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 16:48:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10253000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 16:48:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10253000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 16:48:03+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 16:48:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10253000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 16:48:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,205100000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 16:48:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.05
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 16:48:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,205100000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 16:48:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.05
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 16:48:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,208458000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 16:48:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.05
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,2017-07-01,2017-09-30,2018-11-16 17:32:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,148000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,2017-07-01,2017-09-30,2018-11-16 17:32:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,148000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,2017-07-01,2017-09-30,2018-11-16 17:32:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,148000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,2017-07-01,2017-09-30,2018-11-16 17:32:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2965000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,2017-07-01,2017-09-30,2018-11-16 17:32:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9721000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,2017-07-01,2017-09-30,2018-11-16 17:32:01+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1595000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,2017-07-01,2017-09-30,2018-11-16 17:32:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14281000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,2017-07-01,2017-09-30,2018-11-16 17:32:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14133000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,2017-07-01,2017-09-30,2018-11-16 17:32:01+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5465000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,2017-07-01,2017-09-30,2018-11-16 17:32:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3673000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,2017-07-01,2017-09-30,2018-11-16 17:32:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9138000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,2017-07-01,2017-09-30,2018-11-16 17:32:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-23271000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,2017-07-01,2017-09-30,2018-11-16 17:32:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23271000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,2017-07-01,2017-09-30,2018-11-16 17:32:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23271000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,2017-07-01,2017-09-30,2018-11-16 17:32:01+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,2017-07-01,2017-09-30,2018-11-16 17:32:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-23271000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,2017-07-01,2017-09-30,2018-11-16 17:32:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,281486000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,2017-07-01,2017-09-30,2018-11-16 17:32:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,2017-07-01,2017-09-30,2018-11-16 17:32:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,281486000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,2017-07-01,2017-09-30,2018-11-16 17:32:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,2017-07-01,2017-09-30,2018-11-16 17:32:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,290900000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,2017-07-01,2017-09-30,2018-11-16 17:32:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,32000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,32000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,32000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3204000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13293000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1511000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18008000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17976000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3902000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5121000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9023000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-26999000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26999000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26999000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,1266000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-28265000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,240000000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,240000000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,242849000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.1
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:21:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,132000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:21:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,132000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:21:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,132000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:21:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3005000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:21:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4733000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:21:44+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1210000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:21:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8948000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:21:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8816000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:21:44+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3109000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:21:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-9620000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:21:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-12729000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:21:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-21545000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:21:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21545000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:21:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21545000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:21:44+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,10056000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:21:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-31601000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:21:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,351100000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:21:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:21:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,351100000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:21:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:21:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,356162000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:21:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:21:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,278000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:21:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,278000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:21:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,278000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:21:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14449000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:21:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5282000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:21:13+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,901000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:21:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20632000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:21:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-20354000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:21:13+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4118000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:21:13+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3295000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:21:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-823000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:21:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-21177000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:21:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21177000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:21:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21177000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:21:13+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,3535000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:21:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-24712000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:21:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,424992000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:21:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:21:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,424992000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:21:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:21:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,411900000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:21:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:17:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,453000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:17:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,453000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:17:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,453000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:17:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3531000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:17:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4296000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:17:28+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1945000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:17:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9772000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:17:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9319000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:17:28+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1825000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:17:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,23722000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:17:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,21897000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:17:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12578000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:17:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12578000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:17:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,12578000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:17:28+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,4175000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:17:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8403000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:17:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,461040.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:17:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.02
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:17:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,516300.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:17:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.02
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:17:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,420200000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:17:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.02
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,-451000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,-451000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-451000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1526000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3843000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-2828000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2541000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2992000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,734000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1924000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2658000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5650000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5650000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5650000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,-1000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5649000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,446300000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.01
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,446300000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.01
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,440016000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.01
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,2019-01-01,2019-03-31,2020-06-23 18:56:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,339000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,2019-01-01,2019-03-31,2020-06-23 18:56:00+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,339000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,2019-01-01,2019-03-31,2020-06-23 18:56:00+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,339000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,2019-01-01,2019-03-31,2020-06-23 18:56:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3562000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,2019-01-01,2019-03-31,2020-06-23 18:56:00+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3004000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,2019-01-01,2019-03-31,2020-06-23 18:56:00+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1539000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,2019-01-01,2019-03-31,2020-06-23 18:56:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8105000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,2019-01-01,2019-03-31,2020-06-23 18:56:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7766000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,2019-01-01,2019-03-31,2020-06-23 18:56:00+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1544000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,2019-01-01,2019-03-31,2020-06-23 18:56:00+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-11636000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,2019-01-01,2019-03-31,2020-06-23 18:56:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-13180000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,2019-01-01,2019-03-31,2020-06-23 18:56:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-20946000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,2019-01-01,2019-03-31,2020-06-23 18:56:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20946000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,2019-01-01,2019-03-31,2020-06-23 18:56:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20946000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,2019-01-01,2019-03-31,2020-06-23 18:56:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-20946000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,2019-01-01,2019-03-31,2020-06-23 18:56:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,529133000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,2019-01-01,2019-03-31,2020-06-23 18:56:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,2019-01-01,2019-03-31,2020-06-23 18:56:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,529133000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,2019-01-01,2019-03-31,2020-06-23 18:56:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,2019-01-01,2019-03-31,2020-06-23 18:56:00+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,523700000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,2019-01-01,2019-03-31,2020-06-23 18:56:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:21:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,581000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:21:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,581000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:21:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,581000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:21:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3013000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:21:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3291000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:21:13+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,914000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:21:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7218000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:21:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6637000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:21:13+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:21:13+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,6859000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:21:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,6856000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:21:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,219000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:21:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,219000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:21:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,219000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:21:13+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:21:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,219000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:21:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,550214.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:21:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:21:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,597375.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:21:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:21:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:17:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,593000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:17:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,593000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:17:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,593000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:17:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2838000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:17:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3409000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:17:28+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,802000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:17:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7049000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:17:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6456000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:17:28+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1228000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:17:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1442000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:17:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,214000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:17:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6242000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:17:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6242000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:17:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6242000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:17:28+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:17:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6242000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:17:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,577130.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:17:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.01
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:17:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,577130.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:17:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.01
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:17:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,624200000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:17:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,897000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,897000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,897000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3128000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3886000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,487000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7501000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6604000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2141000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,15418000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,13277000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6673000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6673000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6673000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6673000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,507400000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.01
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,507400000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.01
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,564188000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.01
